Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DISCK
1126
CALL
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $24.3M | 0.01% |
1,000,000
+397,500
| +66% | +$10.6M |
|
1127
First American
FAF
$7.98B
| $24.2M | 0.01% |
361,644
+4,771
| +1% | +$319K |
|
1128
Southern Copper
SCCO
$138B
| $24.2M | 0.01% |
464,462
-75,692
| -14% | -$4.38M |
|
1129
Royal Bank of Canada
RY
$287B
| $24.2M | 0.01% |
242,769
+15,237
| +7% | +$1.55M |
|
1130
Nutanix
NTNX
$16.1B
| $24.1M | 0.01% |
639,948
+214,699
| +50% | +$8.12M |
|
1131
Option Care Health
OPCH
$3.76B
| $24.1M | 0.01% |
993,737
+645,522
| +185% | +$15M |
|
1132
Bruker
BRKR
$9.4B
| $24.1M | 0.01% |
308,671
-614,422
| -67% | -$51.1M |
|
1133
Sonos
SONO
$2.09B
| $24.1M | 0.01% |
744,469
-138,486
| -16% | -$4.99M |
|
1134
Medtronic
MDT
$112B
| $24.1M | 0.01% |
192,134
-1,384,839
| -88% | -$179M |
|
1135
PUT
iShares US Real Estate ETF
IYR
$4.75B
| $24.1M | 0.01% |
235,000
+167,500
| +248% | +$17.8M |
|
1136
Cohen & Steers
CNS
$4.2B
| $24.1M | 0.01% |
287,189
+105,537
| +58% | +$8.94M |
|
|
BLU
1137
DELISTED
BELLUS Health Inc.
BLU
| $24M | 0.01% |
3,916,200
+3,183,404
| +434% | +$12.1M |
|
1138
The RealReal
REAL
$1.41B
| $24M | 0.01% |
1,822,217
+406,798
| +29% | +$6.03M |
|
1139
PUT
Canadian Imperial Bank of Commerce
CM
$106B
| $24M | 0.01% |
+340,000
| New | +$19.6M |
|
1140
CALL
United States Oil Fund
USO
$2.15B
| $23.9M | 0.01% |
455,200
| – | – |
|
1141
Smith & Nephew
SNN
$13.7B
| $23.9M | 0.01% |
696,613
-147,846
| -18% | -$5.82M |
|
|
UNVR
1142
DELISTED
Univar Solutions Inc.
UNVR
| $23.7M | 0.01% |
996,938
-18,601
| -2% | -$440K |
|
1143
Vanguard Extended Market ETF
VXF
$30B
| $23.7M | 0.01% |
130,157
+21,812
| +20% | +$4.07M |
|
1144
SSR Mining
SSRM
$5.19B
| $23.7M | 0.01% |
1,631,079
+456,725
| +39% | +$7.24M |
|
|
PARA
1145
PUT
DELISTED
Paramount Global Class B
PARA
| $23.7M | 0.01% |
600,500
+265,000
| +79% | +$10.8M |
|
1146
CALL
Regeneron Pharmaceuticals
REGN
$72.9B
| $23.7M | 0.01% |
39,200
-28,800
| -42% | -$17.9M |
|
1147
Emcor
EME
$29.9B
| $23.7M | 0.01% |
205,296
+46,684
| +29% | +$5.59M |
|
1148
Stanley Black & Decker
SWK
$14.5B
| $23.7M | 0.01% |
135,099
+20,021
| +17% | +$3.9M |
|
1149
Service Corp International
SCI
$11.8B
| $23.7M | 0.01% |
392,571
+224,228
| +133% | +$13.6M |
|
1150
CALL
US Global Jets ETF
JETS
$768M
| $23.6M | 0.01% |
1,000,000
+800,000
| +400% | +$18.5M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.